Roles of keratinocyte inflammation in oral cancer: regulating the prostaglandin E2, interleukin-6 and TNF-alpha production of oral epithelial cells by areca nut extract and arecoline.

Betel quid (BQ) chewing is an etiologic factor of oral cancer and submucus fibrosis (OSF). Keratinocyte inflammation is crucial for the pathogenesis of cancer and tissue fibrosis. We found that areca nut (AN) extract (100-400 micro g/ml) induced PGE2 production by KB cells by 2.34- to 23.1-fold and also TNF-alpha production by gingival keratinocytes (GK). Arecoline (0.2-1.2 mM) elevated PGE2 production by KB cells by 2.5- to 6.1-fold. AN extract (200-400 micro g/ml) also induced IL-6 production by GK (7.5- to 8.4-fold) and KB cells. In contrast, arecoline (0.1-1.2 mM) suppressed IL-6 production by GK and KB cells, with 42-81 and 41-63% inhibition, respectively. A 48 h exposure of GK to 800-1200 micro g/ml AN extract led to 37-69% cell death. Arecoline cytotoxicity to GK was noted at concentrations of 0.8-1.2 mM, which led to 28-38% cell death. AN extract (400-800 micro g/ml) induced Cox-2 and IL-6 mRNA expression and also COX-2 protein production by KB cells. IL-6 (5-100 ng/ml) suppressed GK growth by 20-33%, but enhanced oral fibroblast (OMF) and KB cell growth. PGE2 (0.05-5 micro g/ml) and anti-IL-6 antibody (ab) (50-1000 ng/ml) showed little effect on GK and KB cell growth. Incubation of GK and KB cells with aspirin, anti-IL-6 ab and anti-TNF-alpha ab showed little effect on arecoline- and AN-induced cytotoxicity, cell cycle arrest and apoptosis. Exposure to anti-TNF-alpha ab slightly affected arecoline- and AN-modulated PGE2 and IL-6 production by GK and KB cells. Arecoline- and AN-conditioned medium decreased phytohemagglutinin-mediated CD4+ and CD8+ T cell activation. These results indicate that BQ chewing contributes to the pathogenesis of cancer and OSF by impairing T cell activation and by induction of PGE2, TNF-alpha and IL-6 production, which affect oral mucosal inflammation and growth of OMF and oral epithelial cells.

[1]  J. Jeng,et al.  Effects of areca nut, inflorescence piper betle extracts and arecoline on cytotoxicity, total and unscheduled DNA synthesis in cultured gingival keratinocytes. , 2007, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[2]  H. Philipsen,et al.  Betel chewer's mucosa--a review. , 2007, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[3]  W. Millesi,et al.  Oral keratinocytes derived from the peritonsillar mucosa express the proinflammatory cytokine IL-6 without prior stimulation. , 2007, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[4]  N. Mak,et al.  Involvement of tumor necrosis factor (TNF-alpha) in arsenic trioxide induced apoptotic cell death of murine myeloid leukemia cells. , 2002, Toxicology letters.

[5]  E. Mazzoni,et al.  Nitric oxide synthase, arginase and cyclooxygenase are involved in muscarinic receptor activation in different murine mammary adenocarcinoma cell lines. , 2002, International journal of molecular medicine.

[6]  P. Greenberg,et al.  Modulating T-cell immunity to tumours: new strategies for monitoring T-cell responses , 2002, Nature Reviews Cancer.

[7]  J. Jeng,et al.  Modulation of platelet aggregation by areca nut and betel leaf ingredients: roles of reactive oxygen species and cyclooxygenase. , 2002, Free radical biology & medicine.

[8]  J. Monson,et al.  The role of CD8+ T cells in immune responses to colorectal cancer , 2002, Cancer Immunology, Immunotherapy.

[9]  Chau-Jong Wang,et al.  Induction of epidermal proliferation and expressions of PKC and NF-kappaB by betel quid extracts in mouse: the role of lime-piper additives in betel quid. , 2002, Chemico-biological interactions.

[10]  Y. Ho,et al.  Prevention of the areca nut extract-induced unscheduled DNA synthesis of gingival keratinocytes by vitamin C and thiol compounds. , 2002, Oral oncology.

[11]  H. Wu,et al.  Inducing the cell cycle arrest and apoptosis of oral KB carcinoma cells by hydroxychavicol: roles of glutathione and reactive oxygen species , 2002, British journal of pharmacology.

[12]  Y. Urade,et al.  Regulation of Prostaglandin Endoperoxide Synthase-2 and IL-6 Expression in Mouse Bone Marrow-Derived Mast Cells by Exogenous But Not Endogenous Prostanoids1 , 2002, The Journal of Immunology.

[13]  C. J. Chen,et al.  Association between Genetic Polymorphism of Tumor Necrosis Factor-a and Risk of Oral Submucous Fibrosis, a Pre-cancerous Condition of Oral Cancer , 2001, Journal of dental research.

[14]  M. Hüll,et al.  Mechanisms of prostaglandin E2‐induced interleukin‐6 release in astrocytes: possible involvement of EP4‐like receptors, p38 mitogen‐activated protein kinase and protein kinase C , 2001, Journal of neurochemistry.

[15]  C. Chiang,et al.  Oral administration of milk from cows immunized with human intestinal bacteria leads to significant improvements of symptoms and signs in patients with oral submucous fibrosis. , 2001, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[16]  K. Kuwano,et al.  Molecular mechanisms of pulmonary fibrosis and current treatment. , 2001, Current molecular medicine.

[17]  Y. Ho,et al.  Areca nut extract and arecoline induced the cell cycle arrest but not apoptosis of cultured oral KB epithelial cells: association of glutathione, reactive oxygen species and mitochondrial membrane potential. , 2001, Carcinogenesis.

[18]  J. Jeng,et al.  Role of areca nut in betel quid-associated chemical carcinogenesis: current awareness and future perspectives. , 2001, Oral oncology.

[19]  K. Chang,et al.  The effects of arecoline on the release of cytokines using cultured peripheral blood mononuclear cells from patients with oral mucous diseases. , 2001, The Kaohsiung journal of medical sciences.

[20]  Yao-Hsu Yang,et al.  β2‐agonist exerts differential effects on the development of cord blood T cells but not on peripheral blood T cells , 2001, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[21]  K. Gomi,et al.  Prostaglandin E2 Selectively Enhances the IgE-Mediated Production of IL-6 and Granulocyte-Macrophage Colony-Stimulating Factor by Mast Cells Through an EP1/EP3-Dependent Mechanism1 , 2000, The Journal of Immunology.

[22]  H. Frucht,et al.  Cholinergic receptor up-regulates COX-2 expression and prostaglandin E(2) production in colon cancer cells. , 2000, Carcinogenesis.

[23]  Z Chen,et al.  Cyclooxygenase regulates human oropharyngeal carcinomas via the proinflammatory cytokine IL‐6: a general role for inflammation? , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[24]  Y. Ho,et al.  Areca nut extract up-regulates prostaglandin production, cyclooxygenase-2 mRNA and protein expression of human oral keratinocytes. , 2000, Carcinogenesis.

[25]  T. Hirano,et al.  Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors , 2000, Oncogene.

[26]  R. Flavell,et al.  The JNK and P38 MAP kinase signaling pathways in T cell-mediated immune responses. , 2000, Free radical biology & medicine.

[27]  A. Hoeflich,et al.  Interleukin-6 stimulates clonogenic growth of primary and metastatic human colon carcinoma cells. , 2000, Cancer letters.

[28]  S. Meghji,et al.  Oral submucous fibrosis patients have altered levels of cytokine production. , 2000, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[29]  R. G. Allen,et al.  Oxidative stress and gene regulation. , 2000, Free radical biology & medicine.

[30]  K. Iwatsuki,et al.  Induction of transcription factor AP-2 by inflammatory cytokines in human keratinocytes. , 1999, The Journal of investigative dermatology.

[31]  W. Kobayashi,et al.  Expression of Tumor Necrosis Factor‐α and Interleukin‐6 in Oral Squamous Cell Carcinoma , 1999, Japanese journal of cancer research : Gann.

[32]  S. Takashiba,et al.  Role of soluble interleukin-6 receptor in inflamed gingiva for binding of interleukin-6 to gingival fibroblasts. , 1999, Journal of periodontal research.

[33]  C. Sotiriou,et al.  The aspirin metabolite salicylate inhibits breast cancer cells growth and their synthesis of the osteolytic cytokines interleukins-6 and -11. , 1999, Anticancer research.

[34]  H. Tsukamoto,et al.  Cytokine regulation of hepatic stellate cells in liver fibrosis. , 1999, Alcoholism, clinical and experimental research.

[35]  J. Shah,et al.  Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. , 1999, Cancer research.

[36]  S. Meghji,et al.  Immunolocalization of cytokines and growth factors in oral submucous fibrosis. , 1998, Cytokine.

[37]  G. Clayman,et al.  Variable expression of cytokines in human head and neck squamous cell carcinoma cell lines and consistent expression in surgical specimens. , 1998, Cancer research.

[38]  M. Luster,et al.  Anthralin stimulates keratinocyte-derived proinflammatory cytokines via generation of reactive oxygen species , 1998, Inflammation Research.

[39]  J. Jeng,et al.  Cytotoxic and cytostatic effects of arecoline on oral mucosal fibroblasts. , 1997, Proceedings of the National Science Council, Republic of China. Part B, Life sciences.

[40]  J. Parsonnet Molecular mechanisms for inflammation-promoted pathogenesis of cancer--The Sixteenth International Symposium of the Sapporo Cancer Seminar. , 1997, Cancer research.

[41]  R. Oyasu,et al.  Transformation in vitro of a nontumorigenic rat urothelial cell line by tumor necrosis factor-alpha. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[42]  S. Kondo,et al.  Penetration of keratinocyte‐derived cytokines into basement membrane , 1997, Journal of cellular physiology.

[43]  S. Sasaki,et al.  IL-6 antisense-mediated growth inhibition of a choriocarcinoma cell line: an intracellular autocrine growth mechanism. , 1996, Gynecologic oncology.

[44]  Y. Jin,et al.  Studies on promoting activity of Taiwan betel quid ingredients in hamster buccal pouch carcinogenesis. , 1996, European journal of cancer. Part B, Oral oncology.

[45]  C. Tsai,et al.  In vitro production of interleukin-6 by human gingival, normal buccal mucosa, and oral submucous fibrosis fibroblasts treated with betel-nut alkaloids. , 1995, Gaoxiong yi xue ke xue za zhi = The Kaohsiung journal of medical sciences.

[46]  M. Feldmann,et al.  Modulation of proinflammatory cytokine release in rheumatoid synovial membrane cell cultures. Comparison of monoclonal anti TNF-alpha antibody with the interleukin-1 receptor antagonist. , 1995, European cytokine network.

[47]  M. Feldmann,et al.  Monoclonal anti‐TNFα Antibody as a Probe of Pathogenesis and Therapy of Rheumatoid Disease , 1995, Immunological reviews.

[48]  M. Miller,et al.  Induction of interleukin-6 in the epidermis of mice in response to tumor-promoting agents. , 1994, Carcinogenesis.

[49]  J. Jeng,et al.  Genotoxic and Non-genotoxic Effects of Betel Quid Ingredients on Oral Mucosal Fibroblasts in vitro , 1994, Journal of dental research.

[50]  K. Ohta,et al.  Growth inhibition of human lung cancer cell lines by interleukin 6 in vitro: a possible role in tumor growth via an autocrine mechanism. , 1993, Cancer research.

[51]  R. Selvan,et al.  Influence of arecoline on immune system: III. Suppression of B cell-mediated immune response in mice after short-term exposure. , 1993, Immunopharmacology and immunotoxicology.

[52]  A. Gori,et al.  Acute-phase proteins and interleukin 6 serum level in head and neck cancer. , 1992, Archives of otolaryngology--head & neck surgery.

[53]  J. Loré,et al.  Surgery vs Chemotherapy-Reply , 1992 .

[54]  R. Grafström,et al.  Effects of areca nut on growth, differentiation and formation of DNA damage in cultured human buccal epithelial cells , 1992, International journal of cancer.

[55]  S. J. Thomas,et al.  Slaked lime and betel nut cancer in Papua New Guinea , 1992, The Lancet.

[56]  E. Fuchs,et al.  Interleukin 6: insights to its function in skin by overexpression in transgenic mice. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[57]  P. Balaram,et al.  Pathogenesis of oral submucous fibrosis. Relationship to risk factors associated with oral cancer , 1992, Cancer.

[58]  A. Gori,et al.  Monocyte Tumor Necrosis Factor Production in Head and Neck Squamous Cell Carcinoma , 1992, The Laryngoscope.

[59]  K. Malik,et al.  Muscarinic receptor-mediated prostacyclin and cGMP synthesis in cultured vascular cells. , 1991, Molecular pharmacology.

[60]  A. Ray,et al.  Expression and function of interleukin‐6 in epithelial cells , 1991, Journal of cellular biochemistry.

[61]  V. Dixit,et al.  Keratinocytes as initiators of inflammation , 1991, The Lancet.

[62]  E. A. Havell,et al.  Tumor necrosis factor-independent IL-6 production during murine listeriosis. , 1991, Journal of immunology.

[63]  T. Kupper Immune and inflammatory processes in cutaneous tissues. Mechanisms and speculations. , 1990, The Journal of clinical investigation.

[64]  S. Weitzman,et al.  Inflammation and cancer: role of phagocyte-generated oxidants in , 2011 .

[65]  J. Rosenbloom,et al.  Cytokine networks in the regulation of inflammation and fibrosis in the lung. , 1990, Chest.

[66]  K Arvidson,et al.  Cytotoxic and genotoxic effects of areca nut-related compounds in cultured human buccal epithelial cells. , 1989, Cancer research.

[67]  H. Stich,et al.  The involvement of reactive oxygen species in oral cancers of betel quid/tobacco chewers. , 1989, Mutation research.

[68]  D. P. Murphy,et al.  Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[69]  A. Zilberstein,et al.  Growth inhibition of human breast carcinoma and leukemia/lymphoma cell lines by recombinant interferon-beta 2. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[70]  T. Elattar,et al.  Cancer and the prostaglandins: a mini review on cancer research. , 1985, Journal of oral pathology.

[71]  L. Marnett,et al.  Prostaglandins and cancer: a review of tumor initiation through tumor metastasis. , 1981, Prostaglandins.

[72]  R. Egan,et al.  Prostaglandins, arachidonic acid, and inflammation. , 1980, Science.

[73]  V. Devita,et al.  IARC monographs on the evaluation of carcinogenic risk of chemicals to humans. , 1980, American Industrial Hygiene Association journal.

[74]  R. L. Carter,et al.  IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans , 1980, IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans.

[75]  P. Grassi IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man: Vol. 11: Cadmium, Nickel, Some Epoxides, Miscellaneous Industrial Chemicals and General Considerations on Volatile Anaesthetics , 1977, British Journal of Cancer.

[76]  I. Ishikawa,et al.  Binary regulation of interleukin (IL)-6 production by EP1 and EP2/EP4 subtypes of PGE2 receptors in IL-1beta-stimulated human gingival fibroblasts. , 2002, Journal of periodontal research.

[77]  M. Kuo,et al.  Quantitative analysis of immunocompetent cells in oral submucous fibrosis in Taiwan. , 2002, Oral oncology.

[78]  H. Endo,et al.  Induction of IL-6 via the EP3 subtype of prostaglandin E receptor in rat adjuvant-arthritic synovial cells , 2001, Inflammation Research.

[79]  J. Shelhamer,et al.  Prostaglandin E(2)-induced interleukin-6 release by a human airway epithelial cell line. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[80]  J. Shelhamer,et al.  Prostaglandin E2-induced interleukin-6 release by a human airway epithelial cell line , 2001 .

[81]  D. Lopez,et al.  Elevated GM-CSF levels in tumor bearing mice upregulate IL-6 production by B cells via a mechanism independent of TNF-alpha. , 2000, International journal of oncology.

[82]  S. Kunkel,et al.  Novel roles for chemokines and fibroblasts in interstitial fibrosis. , 1998, Kidney international.

[83]  T. Hirano Interleukin 6 and its receptor: ten years later. , 1998, International reviews of immunology.

[84]  R. Sharan Association of betel nut with carcinogenesis , 1996 .

[85]  M. Selvakumaran,et al.  Influence of arecoline on immune system: II. Suppression of thymus-dependent immune responses and parameter of non-specific resistance after short-term exposure. , 1991, Immunopharmacology and immunotoxicology.

[86]  J. Van Snick Interleukin-6: an overview. , 1990, Annual review of immunology.

[87]  J. Snick,et al.  Interleukin-6: an overview. , 1990, Annual review of immunology.

[88]  H. Bartsch,et al.  Formation of reactive oxygen species and of 8-hydroxydeoxyguanosine in DNA in vitro with betel quid ingredients. , 1987, Chemico-biological interactions.